Literature DB >> 2208788

In vitro production of B cell growth factor and B cell differentiation factor by peripheral blood mononuclear cells and bronchoalveolar lavage T lymphocytes from patients with idiopathic pulmonary fibrosis.

M Emura1, S Nagai, M Takeuchi, M Kitaichi, T Izumi.   

Abstract

The activation of B lymphocytes and formation of immune complexes have been suggested to play an important role in the pathogenesis of idiopathic pulmonary fibrosis (IPF). To investigate the mechanisms of activation of B lymphocytes, we studied the production of B cell growth factor (BCGF) and B cell differentiation factor (BCDF) in patients with IPF and those with interstitial pneumonia associated with collagen vascular diseases (IP-CVD), in comparison with healthy controls. Culture supernatants of peripheral blood mononuclear cells from patients with IPF induced more IgM and IgA production by B lymphocytes than those from healthy controls, indicating a higher production of BCDF in the patients. Culture supernatants of T lymphocytes obtained from bronchoalveolar lavage fluids (BALF) of patients with IPF induced higher proliferation of B lymphocytes than those from healthy controls, indicating a higher production of BCGF. An increase in production of BCGF and BCDF was not observed in patients with IP-CVD. In the light of these results, it was suggested that there may be an imbalance in T lymphocyte subsets that release lymphokines like BCGF and BCDF in patients with IPF, and that the subsets may differ between blood and BALF. It remains to be elucidated whether the activation of B lymphocytes depending on T lymphocytes determines the development of disease in IPF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2208788      PMCID: PMC1535146          DOI: 10.1111/j.1365-2249.1990.tb05416.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Effect of recombinant IL 2 and gamma-IFN on proliferation and differentiation of human B cells.

Authors:  T Nakagawa; T Hirano; N Nakagawa; K Yoshizaki; T Kishimoto
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

2.  T-lymphocyte alveolitis and B-lymphocyte alveolitis: a new classification of interstitial pneumonitis based on broncho-alveolar lavage findings.

Authors:  T Izumi; N Fujimura; S Oshima
Journal:  Asian Pac J Allergy Immunol       Date:  1983-12       Impact factor: 2.310

Review 3.  Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts).

Authors:  R G Crystal; P B Bitterman; S I Rennard; A J Hance; B A Keogh
Journal:  N Engl J Med       Date:  1984-01-19       Impact factor: 91.245

4.  Proliferative responses of normal human B lymphocytes. Development of an assay system for human B cell growth factor (BCGF).

Authors:  A Muraguchi; A S Fauci
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

Review 5.  Interstitial lung disease: current concepts of pathogenesis, staging and therapy.

Authors:  R G Crystal; J E Gadek; V J Ferrans; J D Fulmer; B R Line; G W Hunninghake
Journal:  Am J Med       Date:  1981-03       Impact factor: 4.965

6.  Regulation of the release of alveolar macrophage-derived neutrophil chemotactic factor.

Authors:  J E Gadek; G W Hunninghake; R L Zimmerman; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1980-04

7.  B-cell stimulatory factor 1 activates resting B cells.

Authors:  E M Rabin; J Ohara; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

8.  Abnormal production of and response to B-cell growth factor and B-cell differentiation factor in patients with systemic lupus erythematosus.

Authors:  T Hirose; M Hara; A Kitani; W Hirose; K Norioka; M Kawagoe; H Nakamura
Journal:  Scand J Immunol       Date:  1985-02       Impact factor: 3.487

9.  Differentiation between idiopathic pulmonary fibrosis and interstitial pneumonia associated with collagen vascular diseases by comparison of the ratio of OKT4+ cells and OKT8+ cells in BALF T lymphocytes.

Authors:  S Nagai; N Fujimura; T Hirata; T Izumi
Journal:  Eur J Respir Dis       Date:  1985-07

10.  Human helper T cell factor(s). III. Characterization of B cell differentiation factor I (BCDF I).

Authors:  T Hirano; T Teranishi; K Onoue
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

View more
  18 in total

Review 1.  Fibrotic disease and the T(H)1/T(H)2 paradigm.

Authors:  Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

2.  Interferon-γ Treatment of Human Laryngotracheal Stenosis-Derived Fibroblasts.

Authors:  Kevin Motz; Idris Samad; Linda X Yin; Michael K Murphy; Madhavi Duvvuri; Dacheng Ding; Alexander T Hillel
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-11-01       Impact factor: 6.223

Review 3.  Idiopathic pulmonary fibrosis and a role for autoimmunity.

Authors:  Gerard F Hoyne; Hannah Elliott; Steven E Mutsaers; Cecilia M Prêle
Journal:  Immunol Cell Biol       Date:  2017-03-30       Impact factor: 5.126

4.  Detection of anti-cytokeratin 8 antibody in the serum of patients with cryptogenic fibrosing alveolitis and pulmonary fibrosis associated with collagen vascular disorders.

Authors:  N Dobashi; J Fujita; Y Ohtsuki; I Yamadori; T Yoshinouchi; T Kamei; M Tokuda; S Hojo; H Okada; J Takahara
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

5.  Prostaglandin E₂ protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction.

Authors:  Ryan T Dackor; Jennifer Cheng; James W Voltz; Jeffrey W Card; Catherine D Ferguson; Ryan C Garrett; J Alyce Bradbury; Laura M DeGraff; Fred B Lih; Kenneth B Tomer; Gordon P Flake; Gregory S Travlos; Randle W Ramsey; Matthew L Edin; Daniel L Morgan; Darryl C Zeldin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-08-19       Impact factor: 5.464

6.  Inhalation of sulfur mustard causes long-term T cell-dependent inflammation: possible role of Th17 cells in chronic lung pathology.

Authors:  Neerad C Mishra; Jules Rir-sima-ah; Gary R Grotendorst; Raymond J Langley; Shashi P Singh; Sravanthi Gundavarapu; Waylon M Weber; Juan C Pena-Philippides; Matthew R Duncan; Mohan L Sopori
Journal:  Int Immunopharmacol       Date:  2012-03-28       Impact factor: 4.932

7.  Relationship between plasma cell levels and profile of bronchoalveolar lavage fluid in patients with subacute extrinsic allergic alveolitis.

Authors:  M Drent; S Wagenaar; H van Velzen-Blad; P G Mulder; H C Hoogsteden; J M van den Bosch
Journal:  Thorax       Date:  1993-08       Impact factor: 9.139

8.  Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.

Authors:  W A Wallace; S N Roberts; H Caldwell; E Thornton; A P Greening; D Lamb; S E Howie
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

9.  Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia.

Authors:  C Jakubzick; E S Choi; S L Kunkel; H Evanoff; F J Martinez; R K Puri; K R Flaherty; G B Toews; T V Colby; E A Kazerooni; B H Gross; W D Travis; C M Hogaboam
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

Review 10.  Cellular and molecular mechanisms of fibrosis.

Authors:  T A Wynn
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.